← Leaderboards
Richard J Gumina
Ohio State University
$6,858,885
Attributed
$6,858,885
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,858,885 · 5
By mechanism
R01$5,846,713 · 3
K08$599,672 · 1
R21$412,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Phillip T. Marucha$8,484,198
- David P Carbone$20,647,321
- George Kyriazis$2,503,304
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularPathway InteractionsKnock-OutResponseMediatingMyocardial IschemiaUnited StatesSignal TransductionCellsReperfusion InjuryMediator Of Activation ProteinCardiovascular DiseasesInsightHeartCardiacTranslationsHomeostasisInflammationAdenosineHealingMacrophageExtracellularIn VivoInflammatory
Grant awards (18)
Genetic modulation of inflammation following myocardial infarction$770,190
R01 · FY2025 · HL · contact PI
Influence of T cell genotype/phenotype in atherosclerotic cardiovascular disease$715,066
R01 · FY2025 · HL · contact PI
Genetic modulation of inflammation following myocardial infarction$777,277
R01 · FY2024 · HL · contact PI
Influence of T cell genotype/phenotype in atherosclerotic cardiovascular disease$706,849
R01 · FY2024 · HL · contact PI
Influence of T cell genotype/phenotype in atherosclerotic cardiovascular disease$741,684
R01 · FY2023 · HL · contact PI
Ectonucleotidases in ischemic heart disease$384,167
R01 · FY2021 · HL · contact PI
Ectonucleotidases in ischemic heart disease$514,476
R01 · FY2020 · HL · contact PI
Ectonucleotidases in ischemic heart disease$53,589
R01 · FY2020 · HL · contact PI
Ectonucleotidases in ischemic heart disease$379,080
R01 · FY2019 · HL · contact PI
Ectonucleotidases in ischemic heart disease$402,085
R01 · FY2018 · HL · contact PI
Ectonucleotidases in ischemic heart disease$402,250
R01 · FY2017 · HL · contact PI
Effect of sarcolemmal KATP channels on ROS/RNS generation and calcium handling$120,241
K08 · FY2013 · HL · contact PI
Effect of sarcolemmal KATP channels on ROS/RNS generation and calcium handling$120,241
K08 · FY2012 · HL · contact PI
Effect of sarcolemmal KATP channels on ROS/RNS generation and calcium handling$120,241
K08 · FY2011 · HL · contact PI
CD39-mediated cardiovascular protection$187,500
R21 · FY2010 · HL · contact PI
Effect of sarcolemmal KATP channels on ROS/RNS generation and calcium handling$120,241
K08 · FY2010 · HL · contact PI
CD39-mediated cardiovascular protection$225,000
R21 · FY2009 · HL · contact PI
Effect of sarcolemmal KATP channels on ROS/RNS generation and calcium handling$118,708
K08 · FY2009 · HL · contact PI